Total Payments
$52,323
2024 Payments
$2,934
Companies
62
Transactions
1,400
Medicare Patients
19,022
Medicare Billing
$750,556
Payment Breakdown by Category
Food & Beverage$28,586 (54.6%)
Other$16,081 (30.7%)
Consulting$4,470 (8.5%)
Travel$3,134 (6.0%)
Education$52.23 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $28,586 | 1,371 | 54.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,081 | 9 | 30.7% |
| Consulting Fee | $4,470 | 3 | 8.5% |
| Travel and Lodging | $3,134 | 10 | 6.0% |
| Education | $52.23 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20,755 | 98 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $6,777 | 91 | $0 (2024) |
| Novo Nordisk Inc | $3,092 | 162 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,789 | 124 | $0 (2024) |
| PFIZER INC. | $1,816 | 93 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,786 | 86 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,525 | 80 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,408 | 84 | $0 (2024) |
| Lilly USA, LLC | $1,300 | 62 | $0 (2024) |
| Allergan, Inc. | $1,171 | 89 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,934 | 115 | Boehringer Ingelheim Pharmaceuticals, Inc. ($420.69) |
| 2023 | $3,247 | 145 | GlaxoSmithKline, LLC. ($483.38) |
| 2022 | $2,455 | 131 | Novo Nordisk Inc ($459.03) |
| 2021 | $2,055 | 121 | Novo Nordisk Inc ($328.77) |
| 2020 | $6,107 | 147 | AstraZeneca Pharmaceuticals LP ($3,942) |
| 2019 | $6,228 | 210 | AstraZeneca Pharmaceuticals LP ($1,735) |
| 2018 | $12,773 | 243 | Novartis Pharmaceuticals Corporation ($7,656) |
| 2017 | $16,524 | 288 | Novartis Pharmaceuticals Corporation ($11,663) |
All Payment Transactions
1,400 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $125.89 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Diabetes Care | ||||||
| 12/03/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: Genetic Disease | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Diabetes Care | ||||||
| 10/29/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $30.47 | General |
| Category: Genetic Disease | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: UROLOGY | ||||||
| 10/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Biological | ||||||
| 10/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Cardio-renal | ||||||
| 09/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 70 | 4,221 | 37,218 | $473,911 | $202,778 |
| 2022 | 59 | 3,899 | 36,707 | $338,185 | $151,759 |
| 2021 | 64 | 5,841 | 41,968 | $450,163 | $207,553 |
| 2020 | 73 | 5,061 | 36,006 | $481,749 | $188,466 |
Total Patients
19,022
Total Services
151,899
Medicare Billing
$750,556
Procedure Codes
266
All Medicare Procedures & Services
266 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 101 | 351 | $74,940 | $34,767 | 46.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 134 | 263 | $40,765 | $20,754 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 151 | 253 | $27,830 | $13,796 | 49.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 133 | $21,230 | $11,841 | 55.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 117 | 117 | $25,740 | $11,294 | 43.9% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 53 | 53 | $7,950 | $7,295 | 91.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 93 | 94 | $7,520 | $6,607 | 87.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 101 | $11,080 | $5,809 | 52.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 179 | 545 | $5,450 | $4,578 | 84.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 37 | $9,620 | $4,485 | 46.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 196 | 576 | $12,672 | $4,240 | 33.5% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 29 | 29 | $4,350 | $3,610 | 83.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 189 | 285 | $11,115 | $3,541 | 31.9% |
| 96130 | Evaluation of psychological test, first hour | Office | 2023 | 37 | 37 | $13,690 | $3,425 | 25.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 133 | 150 | $9,000 | $3,083 | 34.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 176 | 307 | $10,745 | $3,066 | 28.5% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 82 | 82 | $4,100 | $3,007 | 73.3% |
| 83735 | Magnesium level | Office | 2023 | 191 | 468 | $10,296 | $2,993 | 29.1% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 55 | 83 | $5,810 | $2,877 | 49.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 98 | 100 | $3,500 | $2,793 | 79.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 22 | 32 | $5,295 | $2,743 | 51.8% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 14 | 34 | $8,550 | $2,711 | 31.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 32 | 69 | $7,245 | $2,493 | 34.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 32 | 70 | $9,100 | $2,462 | 27.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 70 | 264 | $10,032 | $2,442 | 24.3% |
About Dr. John Jernigan, M.D
Dr. John Jernigan, M.D is a Internal Medicine healthcare provider based in Montgomery, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881635480.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Jernigan, M.D has received a total of $52,323 in payments from pharmaceutical and medical device companies, with $2,934 received in 2024. These payments were reported across 1,400 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($28,586).
As a Medicare-enrolled provider, Jernigan has provided services to 19,022 Medicare beneficiaries, totaling 151,899 services with total Medicare billing of $750,556. Data is available for 4 years (2020–2023), covering 266 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Montgomery, AL
- Active Since 06/08/2006
- Last Updated 07/09/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1881635480
Products in Payments
- ENTRESTO (Drug) $20,690
- BYDUREON (Drug) $3,730
- FARXIGA (Drug) $2,328
- XARELTO (Drug) $1,849
- ELIQUIS (Drug) $1,820
- Ozempic (Drug) $1,462
- JARDIANCE (Drug) $1,448
- INVOKANA (Drug) $913.21
- Vascepa (Drug) $909.71
- Edarbyclor (Drug) $788.39
- Dexcom G6 Transmitter (Medical Supply) $705.45
- Kerendia (Drug) $654.30
- SOLIQUA 100/33 (Biological) $587.26
- VRAYLAR (Drug) $582.59
- TRULICITY (Drug) $510.05
- AMVUTTRA (Drug) $465.53
- Rybelsus (Drug) $453.27
- TRELEGY ELLIPTA (Drug) $434.59
- Victoza (Drug) $425.07
- MOUNJARO (Drug) $423.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Montgomery
Dr. April Truett, M.d, M.D
Internal Medicine — Payments: $83,466
Internal Medicine $83,466
Dr. Joel Mccloud, M.d, M.D
Internal Medicine — Payments: $48,226
Internal Medicine $48,226
Leon Davis, Md, MD
Internal Medicine — Payments: $31,916
Internal Medicine $31,916
Dr. Muhammad Athar, M.d, M.D
Internal Medicine — Payments: $31,442
Internal Medicine $31,442
John Eckman, M.d, M.D
Internal Medicine — Payments: $28,791
Internal Medicine $28,791
Dr. Norman Taylor, M.d, M.D
Internal Medicine — Payments: $22,168
Internal Medicine $22,168